HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece
Abstract
Authors
M. Kalogeropoulou M. Barmpouni V. Grammelis A. Rousakis A. Livieratos D. Paraskevis O. Zisimopoulou